An Electronic Pillbox for People With HIV
NCT00071500 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2008-09-26
Summary
Anti-HIV drug regimens can be very complicated. This study will evaluate a new electronic pillbox designed to help people take their anti-HIV drugs correctly.
Conditions
- HIV Infections
Interventions
- DEVICE
-
MedSignals™
An electronic device that is used to improve medication compliance among HIV patients. It allows convenient storage and transport of antiretroviral medications and functions as an aid to compliance by incorporating reminding alarms at dosing times and usage reporting functions.
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Vesta Brue, MBA · Chairman
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-10-31
- Primary Completion
- 2007-06-30
- Completion
- 2009-06-30
Countries
- United States
Study Locations
More Related Trials
-
An HIV Vaccine Preparedness Study
NCT00000915 ·Status: COMPLETED ·Phase: NA
-
HIV Vaccine Study in HIV Positive Patients
NCT01071031 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects
NCT00000845 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
NCT00001386 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Anti-HIV Therapy Intensification
NCT00034086 ·Status: COMPLETED ·Phase: NA
-
Selection of a Protective T Cell-based HIV-1/FIV Vaccine
NCT02389595 ·Status: ACTIVE_NOT_RECRUITING
-
Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs
NCT00099671 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
NCT01428596 ·Status: UNKNOWN ·Phase: PHASE1
-
Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection
NCT00514605 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
NCT01376726 ·Status: COMPLETED ·Phase: PHASE1
-
Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines
NCT00056745 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults
NCT02178800 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects
NCT00002353 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose of Pembrolizumab in HIV-Infected People
NCT03367754 ·Status: TERMINATED ·Phase: PHASE1
-
Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment
NCT00105417 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
NCT00000713 ·Status: COMPLETED ·Phase: PHASE1
-
Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
NCT05187429 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients
NCT00001357 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3
NCT00001064 ·Status: TERMINATED ·Phase: NA
-
A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
NCT00000745 ·Status: COMPLETED ·Phase: PHASE1
-
Performance and Usability Evaluation of the Atomo HIV Self-Test
NCT03755986 ·Status: COMPLETED ·Phase: NA
-
Analysis of Immune Responses to HIV Vaccines
NCT00068978 ·Status: COMPLETED
-
Vaccine Treatment for HIV-Infection
NCT00108654 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults
NCT00073216 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
NCT00000735 ·Status: COMPLETED ·Phase: PHASE1